• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ: BIAF )

1.370 -0.060 (-4.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 76,671
Open 1.410
Bid (Size) 1.350 (96)
Ask (Size) 1.370 (1)
Prev. Close 1.430
Today's Range 1.350 - 1.410
52wk Range 1.250 - 3.620
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 01, 2024
Via Benzinga
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
October 30, 2024
From bioAffinity Technologies, Inc.
Via Business Wire

Performance

YTD
-18.93%
-18.93%
1 Month
-26.74%
-26.74%
3 Month
-16.97%
-16.97%
6 Month
-30.46%
-30.46%
1 Year
-3.01%
-3.01%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 23, 2024
Via Benzinga
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
October 21, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
October 18, 2024
Via Benzinga
bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
October 18, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
October 16, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
October 10, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
Are Pharma Stocks Harmful To Your Financial Health ?
October 09, 2024
Via Talk Markets
bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
October 09, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
August 23, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
September 18, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q2 2024
August 14, 2024
Via InvestorPlace
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
August 14, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 05, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
Crude Oil Falls Sharply; Exxon Mobil Earnings Top Views
August 02, 2024
Via Benzinga
Exposures Fossil Fuels
Nasdaq Tumbles 3%; US Economy Adds 114,000 Jobs In July
August 02, 2024
Via Benzinga
Topics Economy
Exposures Economy
Dow Dips Over 400 Points; Apple Posts Upbeat Earnings
August 02, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 02, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 12, 2024
Via ACCESSWIRE
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
July 09, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 05, 2024
Via ACCESSWIRE
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
June 12, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024
May 15, 2024
Via InvestorPlace
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 15, 2024
From bioAffinity Technologies, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap